RVMD – revolution medicines, inc. (US:NASDAQ)
Stock Stats
News
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress [Yahoo! Finance]
Revolution Medicines Reports First Quarter 2024 Financial Results and Update on Corporate Progress
Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024
Revolution Medicines, Inc. (NASDAQ: RVMD) had its price target raised by analysts at Oppenheimer Holdings Inc. from $43.00 to $45.00. They now have an "outperform" rating on the stock.
Revolution Medicines: An Expensive Shot At A Massive Market Opportunity [Seeking Alpha]
Form S-3ASR Revolution Medicines,
Form 10-Q Revolution Medicines, For: Mar 31
Form 8-K Revolution Medicines, For: May 08
Form 4 Revolution Medicines, For: May 03 Filed by: Anders Jack
Form 144 Revolution Medicines, Filed by: Anders Jack
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.